The global neurovascular catheters market size is anticipated to reach USD 4.6 billion by 2027, expanding at a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for minimally invasive neurosurgical procedures, rising prevalence of stroke and brain aneurysm, and technological advancements are driving the market.

Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke caused due to reduced blood supply to the brain, making brain cells to die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with U.S. being the most commonly affected country.

Various initiatives are undertaken by the government worldwide to prevention stroke. For instance, the Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program was started by the U.S. CDC in three states: North Carolina, Massachusetts, and Arizona, to minimize the risk of stroke and other neurovascular diseases in women by promoting a healthy lifestyle.

Further Key findings from the study suggest:

  • By type, embolization neurovascular catheters dominated the neurovascular catheters market in 2019 owing to increasing prevalence of conditions, such as brain aneurysms, nose bleeding, and arteriovenous malformations
  • Based on application, the others segment is expected to expand at the highest CAGR during the forecast period owing to rising number of patients suffering from neurovascular diseases and conditions, such as carotid artery stenosis and atherosclerosis
  • Based on end use, hospitals dominated the market in 2019 owing to factors, such as rising prevalence of acute ischemic stroke, growing awareness among population, and increasing government funding
  • North America dominated the market with the largest share in 2019 owing to rising incidence of hemorrhagic stroke and brain aneurysm and increasing R&D investment
  • Some of the key players operating in the neurovascular catheters market are Medtronic; Stryker; phenox GmbH; Penumbra, Inc.; Integer holdings Corporation; Terumo Corporation; Integra LifeSciences Corporation; Biomerics; Acandis GmbH; and Spiegelberg GmbH & Co. KG.